Skip to main content

Table 1 Baseline characteristics of subjects included in the analysis*

From: Differences in aqueous humor protein profiles in patients with proliferative diabetic retinopathy before and after aflibercept treatment

Variables

 

PDR patients (n = 5)

Age, y

 

53.0 ± 8.7

Male gender (%)

 

3 (60.0)

Right Eye (number (%))

 

5 (100.0)

DM history, y

 

13.0 ± 8.0

BCVA (LogMAR)

 

1.5 ± 1.0

Axial length (mm)

 

22.7 ± 1.0

IOP (mmHg)

 

16.5 ± 4.0

Staging of PDR

IV

1 (20.0)

 

V

2 (40.0)

 

VI

2 (40.0)

  1. *Quantitative data and qualitative data are expressed as the mean ± SD and number of people (%), respectively. PDR, proliferative diabetic retinopathy; DM, diabetes mellitus; BCVA, best corrected visual acuity; IOP, intraocular pressure